In this roundtable discussion with Dr. John Gribben, University of London, and Dr. Constantine Tam, Peter MacCallum Cancer Centre, Patient Power Founder, Andrew Schorr, asks the panelists to discuss the current frontline treatment advances for CLL. Listen as new research is discussed, including survival advantages and durable control, as well as cumulative toxicity and cost.
Where Are We Headed With Frontline CLL... - CLL America Support
Where Are We Headed With Frontline CLL Treatment Approaches?
Written by
mcints
To view profiles and participate in discussions please or .
Not what you're looking for?
You may also like...
obinutuzumab + venetoclax
Scheduled to start treatment end of the month to have CLL under control.
Felt fine otherwise and...
Encouraging Tests on Green Tea Extract
mayoclinic.org/discussion/green-tea-extract-appears-to-keep-cancer-in-check-in-majority-of-cll-patie